Pleuropneumonia-like organisms (Pplo)

Pleuropneumonia-like organisms, also known as Pplo, are a type of mycoplasma - small bacteria without a cell wall. These organisms get their name from their ability to cause pneumonia and other infections in the lungs and pleura (the lining of the lungs).

Mycoplasmas were discovered in 1898, but it was not until 1956 that researchers were able to isolate Pplo from lung samples from people suffering from pneumonia. Since then, mycoplasmas have been identified in many animal species and humans around the world.

Compared to other bacteria, mycoplasmas are very small and lack a cell wall, making them resistant to many antibiotics. Their size is only 0.3-0.8 micrometers in diameter. These organisms are also able to survive conditions of low temperature and long-term storage, making them dangerous pathogens.

The main source of mycoplasma infection is coughing and sneezing from infected people and animals, as well as contact with contaminated surfaces. Once infected, mycoplasmas can cause a variety of illnesses, including pneumonia, bronchitis, sinusitis and other respiratory tract infections.

Treatment of infections caused by Pplo can be difficult due to the resistance of mycoplasmas to many antibiotics. However, some antibiotics, such as azithromycin and doxycycline, can help fight infections caused by these organisms.

In general, Pleuropneumonia-like organisms (Pplo) are a serious disease that can cause a variety of respiratory tract infections. Early detection and treatment can help prevent serious health consequences.

Pleuropneumonia-like organisms or Pplo are microorganisms that cause respiratory disease in humans. They can be either pathogenic or opportunistic bacteria, which under certain conditions can cause serious diseases.

Pplo organisms belong to the class Mollicutes, which includes bacteria, viruses, and protozoa. Myoplasma is one of the representatives of this class. These microbes can cause pneumonia, bronchitis, tuberculosis and other lung diseases.

Mycoplasma can remain in the human body for a lifetime without causing any symptoms. However, when the immune system is weakened, stress or other factors activate dormant parasites. Then mycoplasmas begin to actively multiply and infect various organs, including the lungs.

Treatment of Pplo microorganisms involves the use of broad-spectrum antibiotics. Course duration and